Literature DB >> 22845041

Nanoparticles via nanoprecipitation process.

Audrey Minost1, Jean Delaveau, Marie-Alexandrine Bolzinger, Hatem Fessi, Abdelhamid Elaissari.   

Abstract

Various encapsulation approaches have been explored during the last years in order to encapsulate classical active molecules and new synthesized molecules principally for the in vivo therapy as drug delivery nanocarriers and also for the in vivo biomedical diagnostic. These approaches lead to new and versatile systems exhibiting high encapsulation yields of small molecules mainly. Due to the use of biodegradable polymers, the final particles and dispersions exhibit low cytotoxicity and in some cases total biocompatibility. To enhance local targeting efficiency, nanoparticles are chemically grafted using specific antibody for a specific disease. One of the easiest processes leading to rapid particles formation is the nanoprecipitation. Such process is mainly based on polymer transfer from good solvent to poor solvent condition, leading consequently to nanoparticles formation via self-assembly of precipitated polymer chains. The article discussed some of patents associated with Nanoprecipitation Process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22845041     DOI: 10.2174/187221112802652615

Source DB:  PubMed          Journal:  Recent Pat Drug Deliv Formul        ISSN: 1872-2113


  3 in total

1.  Investigation of Effective Parameters on Size of Paclitaxel Loaded PLGA Nanoparticles.

Authors:  Fatemeh Madani; Seyedeh Sara Esnaashari; Basil Mujokoro; Farid Dorkoosh; Masood Khosravani; Mahdi Adabi
Journal:  Adv Pharm Bull       Date:  2018-03-18

Review 2.  Particles from preformed polymers as carriers for drug delivery.

Authors:  K Miladi; D Ibraheem; M Iqbal; S Sfar; H Fessi; A Elaissari
Journal:  EXCLI J       Date:  2014-02-03       Impact factor: 4.068

3.  Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice.

Authors:  Marta Valenza; Jane Y Chen; Eleonora Di Paolo; Barbara Ruozi; Daniela Belletti; Costanza Ferrari Bardile; Valerio Leoni; Claudio Caccia; Elisa Brilli; Stefano Di Donato; Marina M Boido; Alessandro Vercelli; Maria A Vandelli; Flavio Forni; Carlos Cepeda; Michael S Levine; Giovanni Tosi; Elena Cattaneo
Journal:  EMBO Mol Med       Date:  2015-12       Impact factor: 12.137

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.